Victorian State Government funds expansion of cancer clinical trials through the Victorian Comprehensive Cancer Centre
Minister for Health, The Hon. Jill Hennessy MP announced today that the Victorian Comprehensive Cancer Centre (VCCC) will receive $20 million over four years in new funding to boost clinical trials and speed up the delivery of new cancer treatments for Victorian patients.
Announcing the news at Victorian Comprehensive Cancer Centre building the Minister said, “Our globally-renowned cancer experts are at the forefront of life-changing discoveries that will see more cancer patients beat the deadly disease.”
Capitalising on the world-leading research capability and the critical mass of patients the VCCC alliance represents, this funding will ensure more patients benefit more quickly from new knowledge and discoveries.
Incoming Executive Director of the VCCC, Professor Grant McArthur said, “The additional funding for the VCCC will accelerate the translation of research into better outcomes for patients through a significant boost to Victoria’s clinical trial capabilities in cancer.”
“This support for clinical trials highlights the many factors involved in advancing cancer treatments. We need support from government; we need innovative research; we need insightful clinicians, doctors, and nurses, and of course we need pioneering patients who are willing to participate in trials. This is a true partnership effort that brings benefits for cancer patients in Victoria and around the world.”
Clinical trials form a critical bridge between research discoveries in the lab and the translation of new treatments into patient care. The VCCC alliance of ten research and clinical care institutions provides an unparalleled platform for new and innovative clinical trials that would be difficult for any one organisation to develop alone.
The VCCC’s Clinical Trials Development program is led by renowned clinical trials expert, Professor Mark Rosenthal, Director of the Parkville Cancer Clinical Trials Unit and Medical Oncologist at Peter MacCallum Cancer Centre and the Royal Melbourne Hospital.
“This funding will allow us to work strategically across the VCCC alliance to identify key opportunities to use our scope and scale to really build our clinical trials capability,” said Professor Rosenthal. “Ultimately our partners want to ensure all Victorian cancer patients understand the opportunity and can access trials that may benefit them and will also help others.”
Minister Hennessy also announced $12.2 million in new Victorian Cancer Agency grants focused on further improving the conversion of research into clinical practice and new treatments that deliver better cancer care.
Avalee Weir, Communications Manager,
t. 8559 7222 e. email@example.com
Patients interested in knowing more about clinical trials should contact Cancer Council Victoria on 131120 or www.cancervic.org.au/trials.
About the Victorian Comprehensive Cancer Centre
Founded in the holistic principles of the internationally-recognised Comprehensive Cancer Centre model, the Victorian Comprehensive Cancer Centre is a unique and powerful alliance of 10 leading research and clinical institutions with a shared commitment to working together to advance and accelerate cancer research, treatments, preventions and cures.
The VCCC’s multi-site, multi-disciplinary model brings together the complementary strengths of Peter MacCallum Cancer Centre, Melbourne Health (including The Royal Melbourne Hospital), The University of Melbourne, The Walter and Eliza Hall Institute of Medical Research, The Royal Women’s Hospital, The Royal Children’s Hospital, Western Health, St Vincent’s Hospital Melbourne (including St Vincent's Institute), Austin Health (including the Olivia Newton-John Cancer Research Institute and Austin Lifesciences) and Murdoch Childrens Research Institute.